vTv Therapeutics Income Statement (2014-2025) | VTVT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	0.20M	0.40M	0.93M	0.05M	0.11M	0.13M	0.23M	0.38M	0.18M	0.04M	0.04M	0.03M	0.01M	0.01M	0.23M	2.06M	2.47M	3.38M	4.52M	0.92M	1.83M	0.01M	0.01M	0.01M	-0.22M	0.01M	6.40M	0.99M	0.01M	3.00M	0.01M	2.00M	0.01M	0.14M	0.01M	0.10M	-0.00M	-0.00M	-0.01M	1.00M			0.02M			-0.01M
Operating items
Research & Development	4.14M	4.04M	5.17M	7.38M	5.15M	6.57M	8.13M	11.14M	12.08M	10.64M	11.10M	10.96M	9.62M	8.99M	10.07M	8.94M	8.59M	2.70M	2.80M	2.82M	4.23M	3.66M	4.41M	4.20M	2.51M	1.77M	2.53M	3.10M	2.44M	2.38M	5.40M	3.13M	2.21M	3.06M	3.96M	3.94M	4.69M	2.82M	2.14M	2.65M	3.44M	3.22M	2.23M	2.83M	4.10M	7.02M
Selling, General & Administrative	5.13M	1.59M	2.14M	2.00M	2.30M	2.42M	2.37M	2.58M	2.67M	2.40M	2.25M	2.82M	3.00M	2.57M	2.94M	2.25M	2.74M	2.16M	2.07M	2.39M	2.39M	1.77M	1.99M	2.45M	1.70M	1.07M	2.04M	2.16M	2.24M	2.22M	5.72M	5.35M	1.83M	2.63M	2.39M	3.48M	3.31M	2.54M	2.57M	3.98M	3.72M	3.28M	2.67M	3.67M	3.62M	3.68M
Other Operating Expenses	0.26M	0.29M	0.29M	0.39M	0.56M	0.58M	0.81M	0.19M	0.07M	0.53M
Operating Expenses	9.53M	5.92M	7.60M	9.77M	8.00M	9.57M	11.32M	13.92M	14.82M	13.57M	13.35M	13.78M	12.63M	11.56M	13.01M	11.20M	11.33M	4.86M	4.87M	5.21M	6.62M	5.43M	6.39M	6.65M	4.20M	2.84M	4.57M	5.27M	4.68M	4.60M	11.12M	8.48M	4.04M	5.69M	6.35M	7.43M	8.00M	5.37M	4.71M	6.63M	7.16M	6.51M	4.91M	6.50M	7.72M	10.70M
Operating Income	-7.19M	-5.52M	-6.67M	-9.72M	-7.89M	-9.44M	-11.09M	-13.54M	-14.64M	-13.53M	-13.31M	-13.75M	-12.62M	-11.54M	-12.77M	-9.13M	-8.86M	-1.48M	-0.35M	-4.29M	-4.79M	-5.42M	-6.39M	-6.65M	-4.20M	-2.83M	1.83M	-4.28M	-4.67M	-1.60M	-11.11M	-6.48M	-4.03M	-5.69M	-6.34M	-7.43M	-8.00M	-5.37M	-4.71M	-5.63M	-7.16M	-6.51M	-4.89M	-6.50M	-7.72M	-10.70M
EBIT	-7.19M	-5.52M	-6.67M	-9.72M	-7.89M	-9.44M	-11.09M	-13.54M	-14.64M	-13.53M	-13.31M	-13.75M	-12.62M	-11.54M	-12.77M	-9.13M	-8.86M	-1.48M	-0.35M	-4.29M	-4.79M	-5.42M	-6.39M	-6.65M	-4.20M	-2.83M	1.83M	-4.28M	-4.67M	-1.60M	-11.11M	-6.48M	-4.03M	-5.69M	-6.34M	-7.43M	-8.00M	-5.37M	-4.71M	-5.63M	-7.16M	-6.51M	-4.89M	-6.50M	-7.72M	-10.70M
Non-operating items
Interest & Investment Income		-0.03M	0.11M	-0.04M	-0.04M	0.00M	0.13M	0.02M	0.02M	0.02M	0.02M	0.03M	0.03M	0.04M	0.02M	0.02M	0.02M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.01M				0.00M					0.05M	0.15M	0.15M	0.10M	0.15M	0.13M	0.09M	0.08M	0.55M	0.50M	0.43M	0.33M	0.28M	0.40M
Other Non Operating Income	0.01M	-0.03M	-0.49M	0.66M	-1.51M	-0.00M	0.01M	-0.00M	0.00M	0.00M	-0.02M					0.04M		0.01M												-1.08M	0.63M	-3.23M	-0.17M	0.40M	-0.62M	1.79M	0.34M	-3.64M	0.02M	-0.37M	0.12M	0.09M	0.33M	-0.03M	0.05M	-0.03M
Non Operating Income	0.01M	-0.03M	-0.49M	0.66M	-1.51M	-0.00M	0.01M	-0.00M	0.00M	0.00M	-0.02M					0.04M		0.01M												-1.08M	0.63M	-3.23M	-0.17M	0.40M	-0.62M	1.79M	0.34M	-3.64M	0.02M	-0.37M	0.12M	0.09M	0.33M	-0.03M	0.05M	-0.03M
Net income details
EBT	-12.54M	-5.87M	-7.71M	-9.81M	-10.41M	-9.82M	-11.06M	-13.52M	-14.62M	-13.51M	-13.71M	-14.29M	-13.41M	-12.36M	-13.79M	-9.96M	-9.40M	-1.96M	-2.33M	-3.98M	-5.01M	-5.96M	-6.88M	-7.17M	-4.99M	-2.25M	1.61M	-5.93M	-0.84M	-1.36M	-9.48M	-9.22M	-4.09M	-5.47M	-6.09M	-5.77M	-7.21M	-8.54M	-4.44M	-5.92M	-6.41M	-5.84M	-4.44M	-6.22M	-7.38M	-10.35M
Tax Provisions															0.80M		0.20M				0.10M							0.01M		0.10M		0.20M								0.10M
Profit After Tax	-7.40M	-5.87M	-7.71M	-9.81M	-10.41M	-9.82M	-11.06M	-13.52M	-14.62M	-13.51M	-13.71M	-14.29M	-13.41M	-12.36M	-14.59M	-9.96M	-9.60M	-1.96M	-2.33M	-3.98M	-5.11M	-5.96M	-6.88M	-7.17M	-4.99M	-2.25M	1.61M	-5.94M	-0.84M	-1.47M	-9.48M	-9.42M	-4.09M	-5.47M	-6.09M	-5.77M	-7.21M	-8.54M	-4.44M	-6.02M	-6.41M	-5.84M	-4.44M	-6.22M	-7.38M	-10.35M
Income from Non-Controlling Interests						-5.72M	-7.89M	-9.67M	-10.16M	-9.51M	-9.66M	-10.07M	-9.45M	-8.71M	-10.28M	-7.01M	-6.52M	-1.17M	-1.24M	-1.83M	-2.23M	-2.35M	-2.48M	-2.44M	-1.62M	-0.72M	0.48M	-1.70M	-0.23M	-0.38M	-2.43M	-2.42M	-0.94M	-1.21M	-1.34M	-1.27M	-1.59M	-1.89M	-0.96M	-1.15M	-1.23M	-1.06M	-0.80M	-1.12M	-1.33M	-1.65M
Income from Continuing Operations	-12.54M	-5.87M	-7.71M	-9.81M	-10.41M	-9.82M	-11.06M	-13.52M	-14.62M	-13.51M	-13.71M	-14.29M	-13.41M	-12.36M	-14.59M	-9.96M	-9.60M	-1.96M	-2.33M	-3.98M	-5.11M	-5.96M	-6.88M	-7.17M	-4.99M	-2.25M	1.61M	-5.94M	-0.84M	-1.47M	-9.48M	-9.42M	-4.09M	-5.47M	-6.09M	-5.77M	-7.21M	-8.54M	-4.44M	-6.02M	-6.41M	-5.84M	-4.44M	-6.22M	-7.38M	-10.35M
Consolidated Net Income	-12.54M	-5.87M	-7.71M	-9.81M	-10.41M	-9.82M	-11.06M	-13.52M	-14.62M	-13.51M	-13.71M	-14.29M	-13.41M	-12.36M	-14.59M	-9.96M	-9.60M	-1.96M	-2.33M	-3.98M	-5.11M	-5.96M	-6.88M	-7.17M	-4.99M	-2.25M	1.61M	-5.94M	-0.84M	-1.47M	-9.48M	-9.42M	-4.09M	-5.47M	-6.09M	-5.77M	-7.21M	-8.54M	-4.44M	-6.02M	-6.41M	-5.84M	-4.44M	-6.22M	-7.38M	-10.35M
Income towards Parent Company	-12.54M	-5.87M	-7.71M	-9.81M	-10.41M	-9.82M	-11.06M	-13.52M	-14.62M	-13.51M	-13.71M	-14.29M	-13.41M	-12.36M	-14.59M	-9.96M	-9.60M	-1.96M	-2.33M	-3.98M	-5.11M	-5.96M	-6.88M	-7.17M	-4.99M	-2.25M	1.61M	-5.94M	-0.84M	-1.47M	-9.48M	-9.42M	-4.09M	-5.47M	-6.09M	-5.77M	-7.21M	-8.54M	-4.44M	-6.02M	-6.41M	-5.84M	-4.44M	-6.22M	-7.38M	-10.35M
Net Income towards Common Stockholders	-12.54M	-5.87M	-7.71M	-9.81M	-10.41M	-9.82M	-11.06M	-13.52M	-14.62M	-13.51M	-13.71M	-14.29M	-13.41M	-12.36M	-14.59M	-2.95M	-3.07M	-0.80M	-1.83M	-5.88M	-2.88M	-4.12M	-5.03M	-7.17M	-4.99M	-2.25M	1.61M	-5.94M	-4.24M	-1.09M	-7.05M	-7.01M	-3.15M	-4.26M	-4.75M	-4.50M	-5.62M	-6.65M	-3.48M	-4.87M	-5.18M	-4.78M	-3.63M	-5.09M	-6.05M	-8.70M
Additional items
EPS (Basic)	-7.94			-1.26	-1.33	-0.49	-0.35	-0.42	-0.47	-0.41	-0.42	-0.44	-0.41	-0.38	-0.44	-0.30	-0.31	-0.06	-0.10	-0.26	-0.10	-0.13	-0.13	-0.11	-0.07	-0.03	0.03	-0.08	-0.01	-0.02	-8.19	-0.10	-0.04	-0.05	-9.78	-2.16	-2.69	-3.19	-1.67	-1.17	-0.81	-0.88	-0.50	-0.77	-0.92	-1.08
EPS (Weighted Average and Diluted)																											0.03		-0.07	-0.02	-8.19	-0.10	-0.04	-0.05	-9.78	-2.16	-2.69	-3.19	-1.67	-1.17	-0.81	-0.88	-0.50	-0.77	-0.92	-1.08
Shares Outstanding (Weighted Average)				0.82M	0.82M	0.82M	0.82M	0.82M	0.82M	0.82M	0.82M	0.82M	0.82M	0.82M	0.82M	0.82M	0.82M	0.86M	1.02M	1.26M	1.35M	1.50M	1.50M	1.63M	1.69M	1.78M	1.85M	2.02M	2.03M	2.08M	2.25M	2.25M	2.25M	2.61M	2.61M	2.61M	2.61M	2.61M	2.61M	3.01M	3.01M	3.19M	3.19M	3.19M	3.19M	3.19M
Shares Outstanding (Diluted Average)																											47.14M		58.62M	61.07M	1.57M	66.94M	70.37M	80.49M	1.92M	2.08M	2.08M	2.08M	2.08M	4.14M	6.40M	5.50M	5.77M	6.58M	6.59M	8.06M
EBITDA	-7.19M	-5.52M	-6.67M	-9.72M	-7.89M	-9.44M	-11.09M	-13.54M	-14.64M	-13.53M	-13.31M	-13.75M	-12.62M	-11.54M	-12.77M	-9.13M	-8.86M	-1.48M	-0.35M	-4.29M	-4.79M	-5.42M	-6.39M	-6.65M	-4.20M	-2.83M	1.83M	-4.28M	-4.67M	-1.60M	-11.11M	-6.48M	-4.03M	-5.69M	-6.34M	-7.43M	-8.00M	-5.37M	-4.71M	-5.63M	-7.16M	-6.51M	-4.89M	-6.50M	-7.72M	-10.70M
Interest Expenses	5.35M	0.17M	0.17M	0.54M	0.80M	0.33M		0.00M	0.00M		0.40M	0.56M	0.83M	0.85M	0.85M	0.85M	0.87M	0.82M	0.74M	0.63M	0.51M	0.40M	0.28M	0.17M	0.22M	0.23M	0.07M			0.01M	0.01M	0.00M		0.01M	0.01M		0.00M	0.00M	0.01M							0.01M

Research Tools

vTv Therapeutics Income Statement (2014-2025) | VTVT

Create an account

Sign In

Reset Password

Get Pro for 60% off